{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-011699","form_type":"8-K","ticker":"APLS","cik":"0001492422","company_name":"Apellis Pharmaceuticals, Inc.","filed_at":"2024-01-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.320039+00:00","generated_at":"2026-06-06T20:37:11.143613+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Apellis appoints Adam Townsend as Chief Operating Officer, effective immediately","bullets":["Adam Townsend, 47, previously Chief Commercial Officer since Nov 2018, assumes additional COO role.","Townsend's background includes senior leadership roles at Biogen, including SVP of Corporate Development.","No family relationships with directors or executive officers, and no reportable transactions.","Appointment effective January 16, 2024, by the Board of Directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-011699","json":"https://secwatch.observer/filing/0001193125-24-011699.json","markdown":"https://secwatch.observer/filing/0001193125-24-011699.md","text":"https://secwatch.observer/filing/0001193125-24-011699.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1492422/000119312524011699/0001193125-24-011699-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1492422/000119312524011699/d696780d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T20:37:11.143613+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5404f8c116","claim":"Adam Townsend was appointed as Chief Operating Officer at Apellis Pharmaceuticals, Inc..","evidence_excerpt":"On January 16, 2024, the Board of Directors of Apellis Pharmaceuticals, Inc. (the “Company”) appointed Adam Townsend, the Company’s Chief Commercial Officer, to serve as the Company’s Chief Operating Officer, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1492422/000119312524011699/0001193125-24-011699-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}